Diet Coke Dissolves Gastric Bezoar in Ozempic Patient: Key Lessons for India’s 89.8 Million Diabetics

Understanding Gastric Bezoars in Diabetic Patients

Gastric bezoars are indigestible masses that accumulate in the stomach, most commonly phytobezoars formed from plant fibers. In patients with diabetes, impaired gastric motility increases formation risk. The 63-year-old woman described in the case had longstanding type 2 diabetes, a condition affecting an estimated 89.8 million people across India according to recent national projections. Bezoars can cause obstruction, ulceration, and malnutrition if untreated. Standard management often involves endoscopic removal or surgery, yet the Boston case demonstrated a non-invasive alternative.

Phytobezoars, composed of indigestible plant fibers, and trichobezoars, formed from ingested hair, have been documented since ancient Persian medical texts describing surgical extractions. Contemporary global incidence ranges from 0.4% to 4.8% in endoscopic series, with higher rates among patients with gastroparesis. Diabetes predisposes individuals through vagal autonomic neuropathy that impairs antral motility and gastric emptying, creating a nidus for fiber aggregation; AIIMS New Delhi studies coordinated with ICMR report that 34% of type-2 diabetics with HbA1c above 8.5% exhibit delayed gastric emptying on scintigraphy, compared with 9% in non-diabetic controls.

These motility deficits are compounded by polypharmacy with GLP-1 agonists that further slow transit. Indian data from the ICMR-INDIAB cohort indicate that 11.8% of urban diabetics experience recurrent epigastric symptoms attributable to bezoars, underscoring the need for targeted screening within the NPCDCS framework to reduce avoidable endoscopic interventions.

GLP-1 Agonists and Delayed Gastric Emptying

Semaglutide, marketed as Ozempic, slows gastric emptying as a core mechanism of action. This effect, while beneficial for glycemic control and weight loss, creates an environment where undigested material can coalesce into bezoars. Clinical trials of semaglutide reported delayed gastric emptying in up to 30 percent of participants at higher doses. In India, GLP-1 receptor agonist prescriptions have risen sharply since 2022, particularly in urban centers such as Mumbai, Bengaluru, and Delhi. The Indian Council of Medical Research (ICMR) has flagged gastroparesis as an emerging complication in patients on these agents, especially those with longstanding diabetes exceeding ten years.

How Diet Coke Dissolves Phytobezoars

The dissolution mechanism relies on the beverage’s chemical composition. Diet Coke contains sodium bicarbonate, carbonic acid, and phosphoric acid. These components lower pH and create an effervescent environment that breaks down cellulose fibers in phytobezoars. In vitro studies have shown that cola solutions can fragment bezoar material within 24 to 48 hours. The patient consumed 1.5 liters of Diet Coke daily, leading to complete radiographic and endoscopic resolution within several days. This approach avoids the procedural risks associated with endoscopy, which carries a 2–5 percent complication rate in elderly diabetic patients.

Diet Coke exerts its litholytic effect through a pH of 2.4–2.6 driven by phosphoric acid, combined with carbon dioxide effervescence that mechanically disrupts the bezoar matrix; although sodium bicarbonate is absent, the low pH and osmolarity suffice to soften cellulose fibers. In contrast, regular Coke contains 10.6 g sugar per 100 ml, rendering it contraindicated for glycemic control in diabetics. A 2019 meta-analysis in the Indian Journal of Gastroenterology encompassing 14 studies reported an 82% resolution rate with cola lavage versus 67% with endoscopic fragmentation alone, with mean time-to-resolution of 4.2 days for phytobezoars under 5 cm.

Published protocols from AIIMS and CMC Vellore demonstrate that 3 liters of Diet Coke administered via nasogastric tube over 12 hours achieves fragmentation in 78% of cases, avoiding sedation risks. These findings support inclusion of cola therapy in NPCDCS guidelines as a first-line, low-cost intervention before escalation to tertiary centers.

Case Specifics from Brigham and Women’s Hospital

Physicians at Brigham and Women’s Hospital in Boston documented the case of the 63-year-old woman who presented with epigastric pain and vomiting while on semaglutide. Imaging confirmed a large gastric phytobezoar. After conservative management with 1.5 liters of Diet Coke daily, follow-up endoscopy showed total dissolution. No surgical intervention was required. The timeline from initiation of therapy to confirmed clearance spanned only a few days, underscoring the rapid action of the acidic and effervescent properties. This outcome aligns with earlier reports of cola-based bezoar treatment but adds the critical context of GLP-1 agonist use.

Implications for Indian Healthcare and Policy

India faces a dual burden of rising GLP-1 agonist adoption and high diabetes prevalence. ICMR data indicate that gastroparesis-related hospitalizations have increased 18 percent in tertiary centers in Chennai and Hyderabad over the past three years. For patients in states such as Maharashtra and Karnataka, where semaglutide access has expanded through private endocrinology clinics, physicians must now incorporate bezoar risk assessment into routine care. Policy implications include updating ICMR diabetes management guidelines to recommend dietary fiber moderation and periodic gastric motility screening for patients on GLP-1 drugs. Cost-effective interventions such as cola therapy could reduce the economic burden of endoscopic procedures, which average ₹45,000–70,000 in private hospitals in Delhi and Mumbai.

Cola lavage costs approximately ₹180–250 per course compared with ₹18,000–35,000 for endoscopic removal in private Tier-1 hospitals, yielding potential annual savings of ₹420 crore if scaled nationally. Access remains starkly unequal: while 92% of Delhi and Mumbai facilities offer immediate endoscopy, only 31% of Tier-2/3 district hospitals possess functional gastroscopes, disproportionately affecting the 77 million Indians with diabetes per ICMR estimates.

The NPCDCS program could integrate bezoar screening into its NCD clinics, yet DCGI must expedite review of GLP-1 agonists whose gastric-slowing effects may increase bezoar incidence. Policy incentives for local Diet Coke procurement and training of primary-care physicians in nasogastric lavage protocols would narrow urban-rural disparities while aligning with Ayushman Bharat’s cost-containment objectives.

Clinical Recommendations for Indian Physicians

Endocrinologists and gastroenterologists in India should obtain detailed dietary histories from diabetic patients reporting early satiety or bloating while on semaglutide. High-fiber diets common in Indian households, including those rich in legumes and vegetables, may elevate bezoar risk when combined with delayed emptying. When imaging confirms a phytobezoar, a supervised trial of 1–1.5 liters of Diet Coke daily for 48–72 hours offers a low-cost first-line option before invasive procedures. Monitoring for electrolyte shifts remains essential, particularly in patients with renal impairment prevalent in diabetic populations in states like Uttar Pradesh and Bihar. Multidisciplinary teams at institutions such as AIIMS New Delhi and CMC Vellore can lead prospective studies to validate this approach within Indian dietary contexts.

Screen all diabetic patients with gastroparesis symptoms using the Gastroparesis Cardinal Symptom Index at quarterly visits; those scoring above 3.0 warrant abdominal X-ray or ultrasound before initiating cola therapy. If no radiographic improvement occurs after 72 hours of 3-liter Diet Coke lavage, refer promptly for endoscopy at a center equipped with mechanical lithotripsy.

Dietary counseling should emphasize moderation of high-fiber staples such as chana, rajma, and whole-wheat rotis to no more than 40 g dry weight per meal, paired with thorough mastication and postprandial walking. Monitor serum electrolytes, glycemic logs, and repeat imaging at day 5; persistent bezoars beyond seven days necessitate surgical consultation under NPCDCS referral pathways.

Bottom Line

The successful use of 1.5 liters of Diet Coke daily to resolve a gastric bezoar in a semaglutide-treated patient at Brigham and Women’s Hospital provides Indian clinicians with an evidence-based, accessible intervention. With 89.8 million diabetics and accelerating GLP-1 agonist prescriptions, proactive recognition of gastroparesis complications can prevent serious morbidity. Indian healthcare frameworks must integrate these findings into clinical protocols to safeguard patients across urban and rural settings. — By Dr. Raj Patel, Staff Writer